Evidence map›Paper›PMID 39363941›Full record

ArticleThe South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa2024

Lithium-induced cognitive dysfunction assessed over 1-year hospitalisation: A case report.

Yuji Murase, Masaki Kato, Toshihiko Kinoshita, Yoshiteru Takekita

Abstract readCase Reports
In one paragraph

Article in The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuji MuraseDepartment of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.ORCID https://orcid.org/0009-0004-2639-5810
Masaki KatoDepartment of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.ORCID https://orcid.org/0000-0001-6727-7272
Toshihiko KinoshitaDepartment of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.ORCID https://orcid.org/0000-0001-9901-9753
Yoshiteru TakekitaDepartment of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.ORCID https://orcid.org/0000-0003-2435-4033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lithium-induced neurotoxicity is almost always reversible but can cause irreversible neurological sequelae, namely the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT). As there is no definitive treatment for SILENT, caution is required when administering lithium. Reports on the effect of lithium-effectuated neurotoxicity on cognitive function are limited. We report a case in which high cognitive function was lost after lithium overdose and hardly recovered, as evaluated using multiple neuropsychological tests during a 1-year hospitalisation period. Patient presentation: A 52-year-old man on lithium medication with bipolar disorder was admitted to the intensive care unit because of lithium overdose. The patient achieved lucid consciousness after continuous haemodiafiltration. However, he could not move his body as desired or produce appropriate verbal expressions; thus, he was moved to our psychiatric ward, where his treatment continued. Management and outcome: After several months, the patient was diagnosed with SILENT owing to persistent motor and cognitive dysfunctions. Multiple neuropsychological tests were performed, and cognitive function was evaluated. The Neurobehavioural Cognitive Status Examination showed a worsening trend, and the full intelligence quotient of the Wechsler Adult Intelligence Scale-Third Edition was in the mild intellectual disability range. Conclusion: This is a clear case of cognitive dysfunction due to SILENT and is difficult to treat. Thus, it is crucial to prevent the onset of SILENT. Contribution: This report is valuable because it is one of the few to track changes in cognitive function over time in a patient with SILENT using objective measures over 1 year of hospitalisation.

Indexed as

COGNISTATcognitive dysfunctionirreversible neurological sequelaelithium-induced neurotoxicityneuropsychological testsoverdoseSILENTWAIS

Identifiers

PMID39363941
PMCPMC11447571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.